Methylphenidate – MIMS – Risk of cardiac malformations in infants
01/10/2022
Medicines for human use
Safety update
This article was produced by the HPRA for publication in the October edition of Monthly Index of Medical Specialties (MIMS) and describes the small increased risk of cardiac malformations in infants exposed to methylphenidate-containing medicines during the first trimester of pregnancy.